Share-Based Compensation (Tables)

3 Months Ended

May 05, 2018

Share-Based Compensation [Abstract]

Total Compensation Expense and the Related Tax Benefits Recognized

	Thirteen weeks ended
	May 5,		April 29,
	2018		2017
	($ in millions)
Options and shares purchased under the employee stock purchase plan	$	2	$	2
Restricted stock and restricted stock units		3		3
Total share-based compensation expense	$	5	$	5
Tax benefit recognized	$	1	$	1

Assumptions used to Compute Share-Based Compensation Expense

		Stock Option Plans						Stock Purchase Plan
		May 5,			April 29,			May 5,			April 29,
		2018			2017			2018			2017
Weighted-average risk free rate of interest		2.7	%		2.1	%		1.2	%		0.7	%
Expected volatility		37	%		25	%		30	%		29	%
Weighted-average expected award life (in years)		5.5			5.3			1.0			1.0
Dividend yield		3.1	%		1.7	%		2.1	%		2.0	%
Weighted-average fair value	$	12.35		$	15.58		$	16.49		$	10.33

Options Granted under Stock Option Plans

		Weighted-		Weighted-
	Number	Average		Average
	of	Remaining		Exercise
	Shares	Contractual Life		Price
	(in thousands)	(in years)		(per share)
Options outstanding at the beginning of the year	2,739			$	52.45
Granted	379				44.79
Exercised	(4)				11.66
Expired or cancelled	(23)				50.19
Options outstanding at May 5, 2018	3,091		6.7	$	51.58
Options exercisable at May 5, 2018	2,174		5.6	$	48.91
Options available for future grant at May 5, 2018	8,271

Total Intrinsic Value of Options Exercised

	Thirteen weeks ended
	May 5, 2018		April 29, 2017
	($ in millions)
Exercised	$	—	$	15

Aggregate Intrinsic Value for Stock Options Outstanding and Exercisable

	Thirteen weeks ended
	May 5, 2018		April 29, 2017
	($ in millions)
Outstanding	$	11	$	84
Outstanding and exercisable	$	11	$	74

Information about Stock Options Outstanding and Exercisable

	Options Outstanding				Options Exercisable
		Weighted-
		Average		Weighted-			Weighted-
		Remaining		Average			Average
Range of Exercise	Number	Contractual		Exercise	Number		Exercise
Prices	Outstanding	Life		Price	Exercisable		Price
	(in thousands, except prices per share and contractual life)
$9.85 to $18.84	267	2.3	$	16.39	267	$	16.39
$24.75 to $34.75	457	4.3		32.33	419		32.10
$44.78 to $45.75	708	7.9		44.93	339		45.08
$46.64 to $62.11	699	6.4		61.00	674		61.35
$63.79 to $73.21	960	8.3		68.60	475		67.12
	3,091	6.7	$	51.58	2,174	$	48.91

Restricted Share and Unit Activity

			Weighted-
			Average	Weighted-
		Number	Remaining	Average
		of	Contractual	Grant Date
		Shares	Life	Fair Value
		(in thousands)	(in years)		(per share)
Nonvested at beginning of year		374		$	59.15
Granted (1)		635			47.31
Vested		(80)			62.78
Cancelled (2)		(46)			60.55
Nonvested at May 5, 2018		883	2.5	$	50.22
Aggregate value ($ in millions)	$	44

(1)	Approximately 0.4 million performance-based RSUs were granted during the first quarter of 2018 and are included as granted in the table above. The number of performance-based RSUs that are ultimately earned may vary from 0% to 200% of target depending on the achievement relative to the Company’s predefined financial performance targets.
(2)	Adjustments were made to performance-based RSUs previously granted and are included as cancelled in the table above. These adjustments reflect changes in estimates based upon the Company’s current performance against predefined financial targets.